Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis

Blood Transfusion

Volumn 10, Issue SUPPL. 2, 2012, Pages

  Urbani, Andrea ^a,b   Sirolli, Vittorio ^c   Lupisella, Santina ^a,b   Levi Mortera, Stefano ^a,b   Pavone, Barbara ^c   Pieroni, Luisa ^a,b   Amoroso, Luigi ^c   Di Vito, Roberto ^c   Bucci, Sonia ^c   Bernardini, Sergio ^a,b   Sacchetta, Paolo ^c   Bonomini, Mario ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Haemodialysis; Membrane; Protein adsorption; Proteomics

Indexed keywords

ACTIN; ALPHA 1 ANTITRYPSIN; ALPHA 1 MICROGLOBULIN; ALPHA GLOBIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN C; APOLIPOPROTEIN E; BETA 2 MICROGLOBULIN; CARBONATE DEHYDRATASE I; CELLULOSE TRIACETATE; CLUSTERIN; CYSTATIN; DEFENSIN; FIBRINOGEN; FICOLIN; GUANYLIN; HEMOGLOBIN; HEMOGLOBIN BETA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; POLYSULFONE; PREALBUMIN; PROSTAGLANDIN H2; RETINOL BINDING PROTEIN 4; SERUM ALBUMIN; SERUM AMYLOID A; TRANSFERRIN; UNINDEXED DRUG; VITRONECTIN;

ADSORPTION; AGED; ARTICLE; BETA CHAIN; CLINICAL ARTICLE; CROSSOVER PROCEDURE; DIALYSIS MEMBRANE; FEMALE; HELIXONE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; SILVER STAINING;

EID: 84861778712     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.014S     Document Type: Article

References (49)

1. Eggers PW. Has the incidence of end-stage renal disease in the USA and other countries stabilized? Curr Opin Nephrol Hypertens 2011; 20: 241-5.
2. Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 2005; 16: 3736-41.
3. Sun S, Yue Y, Huang X, Meng D. Protein adsorption on blood-contact membranes. J Membr Sci 2003; 222: 3-18.
4. Lonnemann G, Koch KM, Shaldon S, Dinarello CA. Studies on the ability of hemodialysis membranes to induce, bind and clear human interleukin-1. J Lab Clin Med 1988; 112: 76-86.
5. Anderson JM, Bonfield TL, Ziats NP. Protein adsorption and cellular adhesion and activation on biomedical polymers. Int J Artif Organs 1990; 13: 375-82.
6. Johnson R. Complement activation during extracorporeal therapy: biochemistry, cell biology and clinical relevance. Nephrol Dial Transplant 1994; 9 (Suppl 2): 36-45.
7. Franck RD, Weber J, Dresbach H, et al. Role of contact system activation in hemodialyzer induced thrombogenicity. Kidney Int 2001; 60: 1972-81.
8. Merril EW, Pekala RW, Mahmud NA. Hydrogels for blood contact. In Peppas N (editor): Hydrogels in Medicine and Pharmacy. Cleveland: CRC; 1987; 3: 1-16.
9. Cheung AK, Parker C, Wilcox L, Janatova J. Activation of complement by hemodialysis membranes: polyacrylonitrile binds more C3a than cuprophan. Kidney Int 1990; 37: 1055-59.
10. Valette P, Thomas M, Dejardin P. Adsorption of low molecular weight proteins to hemodialysis membranes: experimental results and stimulations. Biomaterials 1999; 20: 1621-34.
11. Pascal M, Schifferli J. Adsorption of complement factor D by polyacrylonitrile dialysis membrane. Kidney Int 1996; 43: 903-11.
12. Opatrny K Jr. Clinical importance of biocompatibility and its effects on hemodialysis treatment. Nephrol Dial Transplant 2003; 18 (Suppl 5): 41-4.
13. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-57.
14. Horl WH. Hemodialysis membranes: interleukins biocompatibility, and middle molecules. J Am Soc Nephrol 2002; 13 (Suppl 1): 62-71.
15. Locatelli F, Canaud B, Eckardt KU, et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003; 18: 1272-80.
16. Goldman M, Dhaene M, Vanherweghem JL. Removal of b2-microglobulin by adsorption on dialysis membranes. Nephrol Dial Transplant 1987; 2: 576-7.
17. Bouman CS, van Olden RW, Stoutenbeek CP. Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Blood Purif 1998; 16: 261-8.
18. Chanard J, Toupance O, Gillery P, Lavaud S. Evaluation of protein loss during hemofiltration. Kidney Int 1988; 33 (Suppl 24): 114-16.
19. Cheung AK, Hohnholt M, Leypoldt JK, DeSpain M. Hemodialysis membrane biocompatibility: the use of erythropoietin. Blood Purif 1991; 9: 153-63.
20. Rumpf KW, Rieger J, Ansorg R, et al. Binding of antibiotics by dialysis membranes and its clinical relevance. Proc Eur Dial Transplant Assoc 1977; 14: 807-9.
21. Mulzer SR, Brash JL. Identification of plasma proteins adsorbed to hemodialyzers during clinical use. J Biomed Mater Res 1989; 23: 1483-504.
22. Francoise Gachon AM, Mallet J, Tridon A, et al. Analysis of proteins eluted from hemodialysis membranes. J Biomater Sci Polym Ed 1991; 2: 263-76.
23. Fujimori A, Naito H, Miyazachi T. Adsorption of complement, cytokines, and proteins by different dialysis membrane materials: evaluation by confocal laser scanning fluorescence microscopy. Artif Organs 1998; 22: 1014-17.
24. Neveceral P, Markert M, Wauters JP. Role of protein adsorption on haemodialysis-induced complement activation and neutrophil defects. Nephrol Dial Transplant 1995; 10: 372-76.
25. Cornelius RM, Brash JL. Identification of proteins adsorbed to hemodialyser membranes from heparinized plasma. J Biomater Sci Polym Ed 1993; 4: 291-304.
26. Clark WR, Macias WL, Molitoris BA, Wang NH. Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int 1995; 48: 481-8.
27. Tsuchida K, Nakatani T, Sugimura K, et al. Biological reactions resulting from endotoxin adsorbed on dialysis membrane: an in vitro study. Artif Organs 2004; 28: 231-4.
28. Thongboonkerd V. Proteomics in extracorporeal blood purification and peritoneal dialysis. J Prot 2010; 73: 521-6.
29. Bonomini M, Pavone B, Sirolli V, et al. Proteomics characterization of protein adsorption onto hemodialysis membranes. J Proteome Res 2006; 5: 2666-74.
30. Mares J, Thongboonkerd V, Tuma Z, et al. Specific adsorption of some complement activation proteins to polysulfone dialysis membranes during hemodialysis. Kidney Int 2009; 76: 404-13.
31. Aoike I. Clinical significance of protein adsorbable membranes-long-term clinical effects and analysis using a proteomic technique. Nephrol Dial Transplant 2007; 22 (Suppl 5): 13-9.
32. Pavone B, Sirolli V, Bucci S, et al. Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations. Blood Transfusions 2010; 8 (Suppl 3): 113-9.
33. Mares J, Richtrova P, Hricinova A, et al. Proteomic profiling of blood-dialyzer interactome reveals involvement of lectin complement pathway in hemodialysis-induced inflammatory response. Proteomics Clin Appl 2010; 4: 829-8.
34. Urbani A, Lupisella S, Sirolli V, et al. Proteomic analysis of protein adsorption capacity by different haemodialysis membranes. Molecular Biosystem 2012; 8: 1029-39.
35. Chenoweth DE. Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications. Artif Organs 1984; 8: 281-7.
36. Ronco C, Bowry S. Nanoscale modulation of the pore dimensions, size distribution and structure of a new polysulfone-based high-flux dialysis membrane. Int J Artif Organs 2001; 24: 726-35.
37. Ishihama Y, Oda Y, Tabata T, et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 2005; 4: 1265-72.
38. Ward RA, Brinkley KA. A proteomic analysis of proteins removed by ultrafiltration during extracorporeal renal replacement therapy. Contrib Nephrol 2004; 141: 280-91.
39. Pieroni L, Finamore F, Ronci M, et al. Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2E: a comparative study. Mol BioSyst 2011; 7: 630-9.
40. Oleschuk RD, McComb ME, Chow A, et al. Characterization of plasma proteins adsorbed onto biomaterials by MALDI-TOFMS. Biomaterials 2000; 21: 1701-10.
41. Dominiczak MH, Caslake MJ. Apolipoproteins: metabolic role and clinical biochemistry applications. Ann Clin Biochem 2011; 48: 498-515.
42. Cornelius RM, Archambault J, Brash JL. Identification of apolipoprotein A-I as a major adsorbate on biomaterial surfaces after blood or plasma contact. Biomaterials 2002; 23: 3583-7.
43. Magnani A, Barbucci R, Lamponi S, et al. Two-step elution of human serum proteins from different glass-modified bioactive surfaces: a comparative proteomic analysis of adsorption patterns. Electrophoresis 2004; 25: 2413-24.
44. Zhang XL, Ali MA. Ficolins: structure, function and associated diseases. Adv Exp Med Biol 2008; 632: 105-15.
45. Lynch NJ, Roscher S, Hartnung T, et al. L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J Immunol 2004; 172: 1198-202.
46. Kuragano T, Kuno T, Takahashi Y, et al. Comparison of the effects of cellulose triacetate and polysulfone membrane on GPIIb/IIIa and platelet activation. Blood Purif 2003; 21: 176-82.
47. Olafiranye F, Kyaw W, Olafiranye O. Case Report Med 2011; doi: 10.1155/2011/134295.
48. Liu S, Shi W, Liang X, et al. Cellulose triacetate dialyser reduces platelet loss during continuous veno-venous hemofiltration. Blood Purif 2010; 29: 375-82.
49. Werner C, Jacobash H-J. Surface characterization of polymers for medical devices. Int J Artif Organs 1999; 22: 160-76.